Leveraging Molecular Heterogeneity of the Vascular Endothelium for Targeted Drug Delivery and Imaging

 

 Buy Article Permissions and Reprints

ABSTRACT

Patterns of luminal vascular protein expression vary according to tissue of origin, and these so-called vascular zip codes play an important role in the maintenance of normal physiological processes in multiorgan species. These zip codes are also often modified in response to pathology and play a critical role in the response to and recovery from disease. These differentially expressed proteins offer opportunities for organ- and disease-specific ligand-targeted molecular delivery, offering clear pharmacologic advantages to traditional systemic drug delivery. However, this approach depends on the availability of frequently elusive targets. Combinatorial screening is a valuable tool for identifying optimal ligands for targeted delivery to the vasculature, especially when adapted for in vivo selection. Here we discuss molecular heterogeneity of the vascular endothelium and the use of phage display as a combinatorial screening method to exploit this heterogeneity for tissue or disease-specific vascular targeting. We also highlight applications of this approach for both drug delivery and molecular imaging.

REFERENCES

• 1 Pasqualini R, Ruoslahti E. Organ targeting in vivo using phage display peptide libraries.  Nature. 1996;  380(6572) 364-366
  CrossrefPubMedGoogle Scholar
• 2 Rajotte D, Arap W, Hagedorn M, Koivunen E, Pasqualini R, Ruoslahti E. Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display.  J Clin Invest. 1998;  102(2) 430-437
  CrossrefPubMedGoogle Scholar
• 3 Salmi M, Jalkanen S. How do lymphocytes know where to go: current concepts and enigmas of lymphocyte homing.  Adv Immunol. 1997;  64 139-218
  PubMedGoogle Scholar
• 4 Springer T A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm.  Cell. 1994;  76(2) 301-314
  CrossrefPubMedGoogle Scholar
• 5 Katayama Y, Hidalgo A, Furie B C, Vestweber D, Furie B, Frenette P S. PSGL-1 participates in E-selectin-mediated progenitor homing to bone marrow: evidence for cooperation between E-selectin ligands and alpha4 integrin.  Blood. 2003;  102(6) 2060-2067
  CrossrefPubMedGoogle Scholar
• 6 Lapidot T, Dar A, Kollet O. How do stem cells find their way home?.  Blood. 2005;  106(6) 1901-1910
  CrossrefPubMedGoogle Scholar
• 7 Hanahan D, Weinberg R A. The hallmarks of cancer.  Cell. 2000;  100(1) 57-70
  CrossrefPubMedGoogle Scholar
• 8 Folkman J. What is the role of endothelial cells in angiogenesis?.  Lab Invest. 1984;  51(6) 601-604
  PubMedGoogle Scholar
• 9 Gibbs W J, Drew R H, Perfect J R. Liposomal amphotericin B: clinical experience and perspectives.  Expert Rev Anti Infect Ther. 2005;  3(2) 167-181
  CrossrefPubMedGoogle Scholar
• 10 Stavridi F, Palmieri C. Efficacy and toxicity of nonpegylated liposomal doxorubicin in breast cancer.  Expert Rev Anticancer Ther. 2008;  8(12) 1859-1869
  CrossrefPubMedGoogle Scholar
• 11 Arap M A, Lahdenranta J, Mintz P J et al.. Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands.  Cancer Cell. 2004;  6(3) 275-284
  CrossrefPubMedGoogle Scholar
• 12 Arap W, Haedicke W, Bernasconi M et al.. Targeting the prostate for destruction through a vascular address.  Proc Natl Acad Sci U S A. 2002;  99(3) 1527-1531
  CrossrefPubMedGoogle Scholar
• 13 Arap W, Pasqualini R, Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model.  Science. 1998;  279(5349) 377-380
  CrossrefPubMedGoogle Scholar
• 14 Giordano R J, Lahdenranta J, Zhen L et al.. Targeted induction of lung endothelial cell apoptosis causes emphysema-like changes in the mouse.  J Biol Chem. 2008;  283(43) 29447-29460
  CrossrefPubMedGoogle Scholar
• 15 Hajitou A, Trepel M, Lilley C E et al.. A hybrid vector for ligand-directed tumor targeting and molecular imaging.  Cell. 2006;  125(2) 385-398
  CrossrefPubMedGoogle Scholar
• 16 Kolonin M G, Saha P K, Chan L, Pasqualini R, Arap W. Reversal of obesity by targeted ablation of adipose tissue.  Nat Med. 2004;  10(6) 625-632
  CrossrefPubMedGoogle Scholar
• 17 Lahdenranta J, Sidman R L, Pasqualini R, Arap W. Treatment of hypoxia-induced retinopathy with targeted proapoptotic peptidomimetic in a mouse model of disease.  FASEB J. 2007;  21(12) 3272-3278
  CrossrefPubMedGoogle Scholar
• 18 Oh P, Li Y, Yu J et al.. Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy.  Nature. 2004;  429(6992) 629-635
  CrossrefPubMedGoogle Scholar
• 19 Paoloni M C, Tandle A, Mazcko C et al.. Launching a novel preclinical infrastructure: comparative oncology trials consortium directed therapeutic targeting of TNFalpha to cancer vasculature.  PLoS One. 2009;  4(3) e4972
  CrossrefPubMedGoogle Scholar
• 20 Veenendaal L M, Jin H, Ran S et al.. In vitro and in vivo studies of a VEGF121/rGelonin chimeric fusion toxin targeting the neovasculature of solid tumors.  Proc Natl Acad Sci U S A. 2002;  99(12) 7866-7871
  CrossrefPubMedGoogle Scholar
• 21 Zurita A J, Troncoso P, Cardó-Vila M, Logothetis C J, Pasqualini R, Arap W. Combinatorial screenings in patients: the interleukin-11 receptor alpha as a candidate target in the progression of human prostate cancer.  Cancer Res. 2004;  64(2) 435-439
  CrossrefPubMedGoogle Scholar
• 22 Carson-Walter E B, Watkins D N, Nanda A, Vogelstein B, Kinzler K W, St Croix B. Cell surface tumor endothelial markers are conserved in mice and humans.  Cancer Res. 2001;  61(18) 6649-6655
  PubMedGoogle Scholar
• 23 St Croix B, Rago C, Velculescu V et al.. Genes expressed in human tumor endothelium.  Science. 2000;  289(5482) 1197-1202
  CrossrefPubMedGoogle Scholar
• 24 Roesli C, Neri D, Rybak J N. In vivo protein biotinylation and sample preparation for the proteomic identification of organ- and disease-specific antigens accessible from the vasculature.  Nat Protoc. 2006;  1 192-199
  CrossrefPubMedGoogle Scholar
• 25 Scott J K, Smith G P. Searching for peptide ligands with an epitope library.  Science. 1990;  249(4967) 386-390
  CrossrefPubMedGoogle Scholar
• 26 Smith G P. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface.  Science. 1985;  228(4705) 1315-1317
  CrossrefPubMedGoogle Scholar
• 27 Smith G P, Scott J K. Libraries of peptides and proteins displayed on filamentous phage.  Methods Enzymol. 1993;  217 228-257
  PubMedGoogle Scholar
• 28 Jaalouk D E, Ozawa M G, Sun J et al.. The original Pathologische Anatomie Leiden-Endothelium monoclonal antibody recognizes a vascular endothelial growth factor binding site within neuropilin-1.  Cancer Res. 2007;  67(20) 9623-9629
  CrossrefPubMedGoogle Scholar
• 29 Mintz P J, Kim J, Do K A et al.. Fingerprinting the circulating repertoire of antibodies from cancer patients.  Nat Biotechnol. 2003;  21(1) 57-63
  CrossrefPubMedGoogle Scholar
• 30 Vidal C I, Mintz P J, Lu K et al.. An HSP90-mimic peptide revealed by fingerprinting the pool of antibodies from ovarian cancer patients.  Oncogene. 2004;  23(55) 8859-8867
  CrossrefPubMedGoogle Scholar
• 31 Barker T H, Baneyx G, Cardó-Vila M et al.. SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity.  J Biol Chem. 2005;  280(43) 36483-36493
  CrossrefPubMedGoogle Scholar
• 32 Cardó-Vila M, Arap W, Pasqualini R. Alpha v beta 5 integrin-dependent programmed cell death triggered by a peptide mimic of annexin V.  Mol Cell. 2003;  11(5) 1151-1162
  CrossrefPubMedGoogle Scholar
• 33 Kato-Takagaki K, Mizukoshi Y, Yoshizawa Y et al.. Structural and interaction analysis of glycoprotein VI-binding peptide selected from a phage display library.  J Biol Chem. 2009;  284(16) 10720-10727
  CrossrefPubMedGoogle Scholar
• 34 Koivunen E, Arap W, Valtanen H et al.. Tumor targeting with a selective gelatinase inhibitor.  Nat Biotechnol. 1999;  17(8) 768-774
  CrossrefPubMedGoogle Scholar
• 35 Kzhyshkowska J, Workman G, Cardó-Vila M et al.. Novel function of alternatively activated macrophages: stabilin-1-mediated clearance of SPARC.  J Immunol. 2006;  176(10) 5825-5832
  PubMedGoogle Scholar
• 36 O'Neil K T, Hoess R H, Jackson S A, Ramachandran N S, Mousa S A, DeGrado W F. Identification of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library.  Proteins. 1992;  14(4) 509-515
  CrossrefPubMedGoogle Scholar
• 37 Smith G P, Schultz D A, Ladbury J E. A ribonuclease S-peptide antagonist discovered with a bacteriophage display library.  Gene. 1993;  128(1) 37-42
  CrossrefPubMedGoogle Scholar
• 38 Tamm I, Trepel M, Cardó-Vila M et al.. Peptides targeting caspase inhibitors.  J Biol Chem. 2003;  278(16) 14401-14405
  CrossrefPubMedGoogle Scholar
• 39 Koivunen E, Wang B, Ruoslahti E. Isolation of a highly specific ligand for the alpha 5 beta 1 integrin from a phage display library.  J Cell Biol. 1994;  124(3) 373-380
  CrossrefPubMedGoogle Scholar
• 40 McConnell S J, Dinh T, Le M H et al.. Isolation of erythropoietin receptor agonist peptides using evolved phage libraries.  Biol Chem. 1998;  379(10) 1279-1286
  CrossrefPubMedGoogle Scholar
• 41 Goodson R J, Doyle M V, Kaufman S E, Rosenberg S. High-affinity urokinase receptor antagonists identified with bacteriophage peptide display.  Proc Natl Acad Sci U S A. 1994;  91(15) 7129-7133
  CrossrefPubMedGoogle Scholar
• 42 Doorbar J, Winter G. Isolation of a peptide antagonist to the thrombin receptor using phage display.  J Mol Biol. 1994;  244(4) 361-369
  CrossrefPubMedGoogle Scholar
• 43 Gui J, Moyana T, Malcolm B, Xiang J. Identification of a decapeptide with the binding reactivity for tumor-associated TAG72 antigen from a phage displayed library.  Proteins. 1996;  24(3) 352-358
  CrossrefPubMedGoogle Scholar
• 44 Fukuda M N, Ohyama C, Lowitz K et al.. A peptide mimic of E-selectin ligand inhibits sialyl Lewis X-dependent lung colonization of tumor cells.  Cancer Res. 2000;  60(2) 450-456
  PubMedGoogle Scholar
• 45 Giordano R J, Cardó-Vila M, Lahdenranta J, Pasqualini R, Arap W. Biopanning and rapid analysis of selective interactive ligands.  Nat Med. 2001;  7(11) 1249-1253
  CrossrefPubMedGoogle Scholar
• 46 Nishimura S, Takahashi S, Kamikatahira H et al.. Combinatorial targeting of the macropinocytotic pathway in leukemia and lymphoma cells.  J Biol Chem. 2008;  283(17) 11752-11762
  CrossrefPubMedGoogle Scholar
• 47 Giordano R J, Anobom C D, Cardó-Vila M et al.. Structural basis for the interaction of a vascular endothelial growth factor mimic peptide motif and its corresponding receptors.  Chem Biol. 2005;  12(10) 1075-1083
  CrossrefPubMedGoogle Scholar
• 48 Folkman J. Fundamental concepts of the angiogenic process.  Curr Mol Med. 2003;  3(7) 643-651
  CrossrefPubMedGoogle Scholar
• 49 Folkman J. Angiogenesis: an organizing principle for drug discovery?.  Nat Rev Drug Discov. 2007;  6(4) 273-286
  CrossrefPubMedGoogle Scholar
• 50 Kolonin M G, Bover L, Sun J et al.. Ligand-directed surface profiling of human cancer cells with combinatorial peptide libraries.  Cancer Res. 2006;  66(1) 34-40
  CrossrefPubMedGoogle Scholar
• 51 Arap M A, Lahdenranta J, Hajitou A et al.. Model of unidirectional transluminal gene transfer.  Mol Ther. 2004;  9(2) 305-310
  PubMedGoogle Scholar
• 52 Ardelt P U, Wood C G, Chen L et al.. Targeting urothelium: ex vivo assay standardization and selection of internalizing ligands.  J Urol. 2003;  169(4) 1535-1540
  CrossrefPubMedGoogle Scholar
• 53 Shukla G S, Krag D N. Selection of tumor-targeting agents on freshly excised human breast tumors using a phage display library.  Oncol Rep. 2005;  13(4) 757-764
  PubMedGoogle Scholar
• 54 Lewis V O, Ozawa M G, Deavers M T et al.. The interleukin-11 receptor alpha as a candidate ligand-directed target in osteosarcoma: consistent data from cell lines, orthotopic models, and human tumor samples.  Cancer Res. 2009;  69(5) 1995-1999
  CrossrefPubMedGoogle Scholar
• 55 Yao V J, Ozawa M G, Trepel M, Arap W, McDonald D M, Pasqualini R. Targeting pancreatic islets with phage display assisted by laser pressure catapult microdissection.  Am J Pathol. 2005;  166(2) 625-636
  CrossrefPubMedGoogle Scholar
• 56 Gordon P H, Moore D H, Miller R G Western ALS Study Group et al. Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.  Lancet Neurol. 2007;  6(12) 1045-1053
  CrossrefPubMedGoogle Scholar
• 57 Benatar M. Lost in translation: treatment trials in the SOD1 mouse and in human ALS.  Neurobiol Dis. 2007;  26(1) 1-13
  CrossrefPubMedGoogle Scholar
• 58 Arap W, Kolonin M G, Trepel M et al.. Steps toward mapping the human vasculature by phage display.  Nat Med. 2002;  8(2) 121-127
  CrossrefPubMedGoogle Scholar
• 59 Pentz R D, Flamm A L, Pasqualini R, Logothetis C J, Arap W. Revisiting ethical guidelines for research with terminal wean and brain-dead participants.  Hastings Cent Rep. 2003;  33(1) 20-26
  PubMedGoogle Scholar
• 60 Kolonin M G, Sun J, Do K A et al.. Synchronous selection of homing peptides for multiple tissues by in vivo phage display.  FASEB J. 2006;  20(7) 979-981
  CrossrefPubMedGoogle Scholar
• 61 Hajitou A, Pasqualini R, Arap W. Vascular targeting: recent advances and therapeutic perspectives.  Trends Cardiovasc Med. 2006;  16(3) 80-88
  CrossrefPubMedGoogle Scholar
• 62 Kolonin M, Pasqualini R, Arap W. Molecular addresses in blood vessels as targets for therapy.  Curr Opin Chem Biol. 2001;  5(3) 308-313
  CrossrefPubMedGoogle Scholar
• 63 Ozawa M G, Zurita A J, Dias-Neto E et al.. Beyond receptor expression levels: the relevance of target accessibility in ligand-directed pharmacodelivery systems.  Trends Cardiovasc Med. 2008;  18(4) 126-132
  CrossrefPubMedGoogle Scholar
• 64 Pasqualini R, Arap W. Profiling the molecular diversity of blood vessels.  Cold Spring Harb Symp Quant Biol. 2002;  67 223-225
  CrossrefPubMedGoogle Scholar
• 65 Trepel M, Arap W, Pasqualini R. In vivo phage display and vascular heterogeneity: implications for targeted medicine.  Curr Opin Chem Biol. 2002;  6(3) 399-404
  CrossrefPubMedGoogle Scholar
• 66 Trepel M, Pasqualini R, Arap W. Chapter 4. Screening phage-display Peptide libraries for vascular targeted peptides.  Methods Enzymol. 2008;  445 83-106
  CrossrefPubMedGoogle Scholar
• 67 Neri D, Bicknell R. Tumour vascular targeting.  Nat Rev Cancer. 2005;  5(6) 436-446
  CrossrefPubMedGoogle Scholar
• 68 Hajitou A, Lev D C, Hannay J A et al.. A preclinical model for predicting drug response in soft-tissue sarcoma with targeted AAVP molecular imaging.  Proc Natl Acad Sci U S A. 2008;  105(11) 4471-4476
  CrossrefPubMedGoogle Scholar
• 69 Hajitou A, Rangel R, Trepel M et al.. Design and construction of targeted AAVP vectors for mammalian cell transduction.  Nat Protoc. 2007;  2 523-531
  CrossrefPubMedGoogle Scholar
• 70 Souza G R, Yonel-Gumruk E, Fan D et al.. Bottom-up assembly of hydrogels from bacteriophage and Au nanoparticles: the effect of cis- and trans-acting factors.  PLoS One. 2008;  3(5) e2242
  CrossrefPubMedGoogle Scholar
• 71 Souza G R, Christianson D R, Staquicini F I et al.. Networks of gold nanoparticles and bacteriophage as biological sensors and cell-targeting agents.  Proc Natl Acad Sci U S A. 2006;  103(5) 1215-1220
  CrossrefPubMedGoogle Scholar
• 72 Souza G R, Levin C S, Hajitou A, Pasqualini R, Arap W, Miller J H. In vivo detection of gold-imidazole self-assembly complexes: NIR-SERS signal reporters.  Anal Chem. 2006;  78(17) 6232-6237
  CrossrefPubMedGoogle Scholar
• 73 Barbas C, Burton D, Silverman G, Scott J. Phage Display: A Laboratory Manual. New York, NY; Cold Spring Harbor Laboratory Press 2001
  PubMedGoogle Scholar
• 74 Marchiò S, Lahdenranta J, Schlingemann R O et al.. Aminopeptidase A is a functional target in angiogenic blood vessels.  Cancer Cell. 2004;  5(2) 151-162
  CrossrefPubMedGoogle Scholar
• 75 Koivunen E, Wang B, Ruoslahti E. Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins.  Biotechnology (N Y). 1995;  13(3) 265-270
  PubMedGoogle Scholar
• 76 Pasqualini R, Koivunen E, Kain R et al.. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.  Cancer Res. 2000;  60(3) 722-727
  PubMedGoogle Scholar
• 77 Mintz P J, Cardó-Vila M, Ozawa M G et al.. An unrecognized extracellular function for an intracellular adapter protein released from the cytoplasm into the tumor microenvironment.  Proc Natl Acad Sci U S A. 2009;  106(7) 2182-2187
  CrossrefPubMedGoogle Scholar
• 78 Burg M A, Pasqualini R, Arap W, Ruoslahti E, Stallcup W B. NG2 proteoglycan-binding peptides target tumor neovasculature.  Cancer Res. 1999;  59(12) 2869-2874
  PubMedGoogle Scholar

Renata PasqualiniPh.D. 

David H. Koch Center, The University of Texas M. D. Anderson Cancer Center

1515 Holcombe Boulevard, Houston, TX 77030

Email: rpasqual@mdanderson.org